1) Hochberg MC:Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725, 1997
2) Trysberg E, Carlsten H, Tarkowski A:Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 9:498-503, 2000
3) Trysberg E, Nylen K, Rosengren LE, et al.:Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 48:2881-2887, 2003
4) 広畑俊成,金井美紀,戸叶嘉明,他:ループス精神病の分類予備基準作成に関する小委員会報告.平成16年度厚生労働科学研究費補助金 免疫アレルギー疾患予防・治療研究事業研究報告書 第一分冊 pp344-345, 2005
5) ACR ad hoc Committee on Neuropsychiatric Lupus Nomenclature:The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599-608, 1999
6) Katsumata Y, Harigai M, Kawaguchi Y, et al:Diagnostic reliability of cerebral spinal fluid tests for acute confusional state(delirium) in patients with systemic lupus erythematosus:interleukin 6(IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J Rheumatol 34:2010-2017, 2007
7) Janka GE:Hemophagocytic syndromes. Blood Rev 21:245-253, 2007
8) Henter J-I, Horne AC, Arico´M, et al.:HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124-131, 2007
9) Komp DM, McNamara J, Buckley P:Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 73:2128-2132, 1989
10) Imashuku S, Hibi S, Sako M, et al.:Soluble interleukin-2 receptor:a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 86:4706-4707, 1995